Vaccine Contract Manufacturing Market Estimates, Share, Vendors, Growth Rate Forecast 2014-2025

Vaccine Contract Manufacturing Market Estimates, Share,
Vendors, Growth Rate Forecast 2014-2025
“Vaccine Contract Manufacturing Market size is expected to reach USD 4.0
billion by 2025, A vaccine provides active acquired immunity to a disease. The
demand for vaccine contract manufacturing is increasing in the market.
Vaccine manufacturing is a complex process, in which effectivity, safety and
consistency are the most important part for the manufacturers.”
Global Vaccine Contract Manufacturing Market size is expected to reach USD 4.0 billion by 2025, A vaccine
provides active acquired immunity to a disease. The demand for vaccine contract manufacturing is increasing in
the market. Vaccine manufacturing is a complex process, in which effectivity, safety and consistency are the
most important part for the manufacturers. It offers many services such as production process, cell line
development, construction & operation of manufacturing product, process optimization, fermentation and
analytical characterization, which fuels the market growth in the coming years. The vaccine contract
manufacturing market registering a CAGR of 9.3% in the upcoming period as the scope, product types, and its
applications are increasing across the globe. Vaccine contract services offer cost-saving benefits to their clients.
Also, they help to save time in operations & management of a research and production facility. The growing
demand for vaccine development from the private sector as well as governments in developing and
industrialized countries is expected to witness significant growth of the market in the coming years. In the
market, various types of vaccines are available such as inactivated vaccines, attenuated vaccines, toxoid-based
vaccines, subunit-based vaccines, DNA-based vaccines, recombinant vector vaccines, synthetic vaccines and
others. The “attenuated vaccines” is expected to hold the large market share in the upcoming period due to
their ability to elicit strong and antibody responses. These vaccines offer lifetime immunities with just one or
two doses. Moreover, proper handling conditions, especially with respect to storage and maintenance will
continue to drive the segment in the coming years.
Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market/request-sample

In addition, in the market some single as well as combination vaccine are available. The single vaccine such as
influenza virus, ebola virus, chickenpox, smallpox, polio, tetanus, tuberculosis and others could be explored in
vaccine contract manufacturing industry. The factors that play an important role in the growth of market include
increasing demand, growing population, increasing urbanization & industrialization, growing pharmaceutical
industry, increase in the number of countries demanding the introduction of vaccines, stringent government
rules & regulations and increasing awareness about vaccination & its benefits in developing countries.
Moreover, increasing prevalence of various bacterial and viral infections is a main factor drive the growth of the
vaccine contract manufacturing market in the next couple of years.
However, high cost of vaccination, regulatory challenges and patent expiration in recent times are negatively
impacting the growth of vaccine contract manufacturing industry. The market is widely analyzed based on
different regional factors such as gross domestic product (GDP), demographics, acceptance, inflation rate and
others. The market is categorized based on vaccine type, product type, workflow, application and geography.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market
The market is classified into workflow such as downstream and upstream. The “downstream” segment is further
segregated into fill & finish operations, packaging and analytical & QC studies whereas the segment “upstream”
is segmented into mammalian expression systems, yeast expression systems, bacterial expression systems,
baculovirus/insect expression systems and others. Vaccine production requires skilled personnel for
downstream as well as upstream processing. The “downstream” segment is expected to witness significant
growth in the coming years owing to the robust demand for downstream processing and sophisticated
equipment for efficient product recovery.
North America is accounting large market share in the years to come owing to widespread manufacturing of
vaccines in this region, coupled with growing presence of large number of biopharmaceutical facilities. State
and the other laws pertaining to development of vaccines & other biologics, particularly in Canada and U.S. are
expected to boost the market growth in this region. On the other hand, Asia Pacific is projected to grow at a
higher CAGR in the next couple of years due to growing population, improving infrastructure in several
developing countries, and growing pharmaceutical industry.
The key players contributing to the robust development of the vaccine contract manufacturing market include
Lonza, Paragon Bioservices Inc., Ajinomoto Althea Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Merck
KGaA, Cytovance Biologics, Catalent Inc., IDT Biologika GmbH, Albany Molecular Research Inc., PRA Health
Sciences, ICON plc., Pharmaceutical Product Development, LLC, and Cobra Bio. The major market players are

focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions,
and joint ventures are the need of the hour.
Market Segment:
Vaccine Contract Manufacturing Vaccine Type Outlook (Revenue, USD Million, 2014 - 2025)
• Attenuated Vaccine
• Inactivated Vaccine
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
Vaccine Contract Manufacturing Workflow Outlook (Revenue, USD Million, 2014 - 2025)
• Downstream
• Fill & Finish Operations
• Analytical & QC studies
• Packaging
• Upstream
• Mammalian Expression Systems
• Bacterial Expression Systems
• Yeast Expression Systems
• Baculovirus/Insect Expression Systems
• Others
Vaccine Contract Manufacturing Application Outlook (Revenue, USD Million, 2014 - 2025)
• Human Use
• Veterinary
Vaccine Contract Manufacturing Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• Asia Pacific
• India
• China
• Latin America

• Brazil
• Middle East & Africa
• South Africa
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/pharmaceuticals
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016
India
Phone: 91-20-65300184